BEVASIRANIB SODIUM
UNII II3PQ3910V

Substance Identification & Data

This profile provides standardized clinical and technical data for Bevasiranib Sodium, uniquely identified by the FDA Unique Ingredient Identifier (UNII) II3PQ3910V.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 849758-52-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
II3PQ3910V
CAS Registry Number
849758-52-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BEVASIRANIB SODIUM
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
USAN ID
SS-08
Identifier assigned by the United States Adopted Names Council.
Substance Type
nucleicAcid
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bevasiranib Sodium. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BEVASIRANIB SODIUM

Common Names & Synonyms

BEVASIRANIB SODIUM [USAN]
BEVASIRANIB SODIUM [WHO-DD]
RNA, (A-C-C-U-C-A-C-C-A-A-G-G-C-C-A-G-C-A-C-DT-DT), EICOSASODIUM SALT, COMPLEX WITH RNA (G-U-G-C-U-G-G-C-C-U-U-G-G-U-G-A-G-G-U-DT-DT) EICOSASODIUM SALT (1:1)

Technical Codes

CAND5